What is Insulin Potentiation Therapy (IPT)?
Updated: Sep 24, 2020
Insulin Potentiation Therapy (IPT) was originally developed by Donato Perez Garcia in the 1930’s. IPT involves administering low levels of chemotherapy or another anti-cancer agent alongside insulin. The purpose of this is three-fold.
First, insulin naturally makes cell membranes more permeable, allowing the chemotherapy to be more easily absorbed. Second, cancer cells have significantly more insulin receptors than normal cells. This means that the cancer cells will attract in more insulin and likewise, chemo.
At Cancer Center for Healing, we add a third step to this therapy which helps boost effectiveness. We know that cancer cells feed on sugar (insulin). As such, before an IPT treatment, we have patients eliminate sugar from their diet entirely. The cancer cells will now be starving for their “food”. As a result, when the chemo is administered with insulin, the cancer cells will rush to consume the sugar and as a result, consume larger amounts of the chemo as well.
Due to increased effectiveness, chemotherapy doses can be reduced by 10-20%. This, in turn, dramatically reduces the negative side effects that typically accompany large doses of chemo.
Furthermore, IPT can be used alongside other natural anti-cancer agents to increase effectiveness. At Cancer Center for Healing, we utilize advanced testing like the RGCC test to identify the most effective anti-cancer substances for each individual patient. We can then administer the identified substances in congruence with IPT.
To learn more, watch the video above where Dr. Suzanne Kim from Cancer Center for Healing explains insulin potentiation therapy in-depth.
Interested in becoming a patient? Call or email us with the information below to schedule your initial consultation!
Call: (949) 581-4673